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Introduction
Bone tissue has a remarkable capacity for regeneration, driven by mechanisms that govern embryonic bone development [1] . Despite this, both internal and external pathological factors can hinder the fracture healing process, resulting in delayed or non-union fractures [2, 3] .
Autologous bone grafting (ABG) remains the current gold standard treatment approach but is hindered by major limitations such as tissue availability and donor site morbidity [4] [5] [6] . Tissue engineering strategies have attempted to produce alternatives, primarily through mimicking the desirable properties of ABG [7, 8] . These approaches, however, mainly aim to mimic mature bone tissue and are therefore intrinsically unresponsive to the important biological cues present during early fracture repair. This has led to the investigation of endochondral ossification [9] , which predominates during embryonic bone formation and is also a key driver of long bone fracture repair postnatally [2, 3] . The cartilaginous callus formed during endochondral fracture repair produces factors that are known to promote angiogenesis and calcification, subsequently promoting matrix remodelling [10] [11] [12] . It has therefore been proposed that recapitulating endochondral ossification, or at least the tissue intermediates involved in this process, may facilitate bone healing more effectively [13] [14] [15] [16] .
Although there have been major advances in the fabrication of synthetic biomaterials, their limited ability to be remodelled during the complex process of tissue formation results in limited integration [17] [18] [19] [20] [21] . Therefore, the use of naturally derived ECM constructs is highly appealing as they should be susceptible to tissue remodelling processes. Indeed, much research has been associated with the use of decellularised tissues from other species to create biological scaffolds. Decellularised biological scaffolds not only retain the original 3D morphological architecture of the tissue but, with appropriate attention to production processes, can also retain a complex mixture of proteins and macromolecules that aid the proliferation and differentiation of endogenous or exogenous cells. Importantly, the structural and functional proteins of the ECM are highly conserved across species. This high degree of homology allows xenogeneic ECM to This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. be implanted in recipients of different species without an immune reaction [22] . The avoidance of tissue rejection in the recipient has catapulted the use of decellularised scaffolds to the forefront of regenerative medicine and tissue engineering, as evidenced by the success of human tracheal implants [23] . Additionally, a number of xenogenic bone void fillers are currently used clinically, such as NuOss™ (Ace Surgical) and Bio-Oss® (Geistlich), which are both derived from bovine bone tissue.
To date, most research incorporating naturally derived decellularised cartilage ECM for endochondral ossification has focused on the use of articular cartilage [24, 25] , a tissue that is known to be highly stable during adult life [26] . Conversely, when considering fracture repair it is likely that a source of cartilage which undergoes hypertrophy and ossification postnatally may offer significant advantages over articular cartilage [27] [28] [29] . Postnatally, costal cartilage represents a plentiful source of cartilage that undergoes these changes.
Costal cartilage is a hyaline cartilage tissue associated with the ribs and contains a region of hypertrophic chondrocytes [30] , thus replicating the developmental bone forming cartilage and the postnatal fracture callus. Interestingly, despite costal cartilage undergoing slow bone formation physiologically in the rib environment, if transplanted subcutaneously it undergoes rapid endochondral remodelling [31] .
Herein, we hypothesise that an optimised decellularisation of costal cartilage will result in non-immunogenic scaffolds that retain the native structure and desirable biological components required to control endochondral ossification.
Materials and methods

Costal cartilage harvest
Fresh porcine costal cartilage was obtained from Large-White/Landrace crossbred pigs ranging from 40 This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. removed using a sterile scalpel and the harvested costal cartilage placed in sterile plastic bags and stored immediately at -20°C.
Development of decellularisation methodology
Frozen costal cartilage samples were defrosted at room temperature. The cartilage tissue was dissected into discs measuring 10 mm in diameter and 1 mm in height, with a volume of 78.5 mm 3 . These discs were allotted into three groups each containing five discs. These groups were subjected to three independent decellularisation methodologies (detailed in Supplementary Table 1 ). All the methodologies were carried out under negative pressure at 2000 µmHg (267 Pa), using a negative pressure desiccator (Sigma-Aldrich, Dorset, UK).
All decellularisation methods utilised 250 mL of solution per step. All methodologies also included a nuclease digestion step to eliminate nucleic acids. The DNAse/RNAse buffers contained 10 mM CaCl 2 and 60 mM MgCl 2 , required for the activity of nucleases. This step was carried out at 37°C under agitation using an orbital shaker (ThermoFisher, Bedford, UK). All non-enzymatic steps were carried out at 4-8ºC.
Vac-OS methodology adapted from Greco and colleagues [32] utilised a freeze/thaw cycle to initiate cell disruption, followed by the use of hyper-and hypotonic steps in order to facilitate cell lysis. Washing with wash buffer containing Tween-20 (Sigma-Aldrich, Dorset, UK) was incorporated between each step to aid the removal fragmented cellular components.
Vac-STx methodology adapted from Lange and colleagues [33] utilised a freeze/thaw cycle to initiate cell disruption, followed by a combination of sodium deoxycholate (SDC) (SigmaAldrich, Dorset, UK) and Triton-X100 (Sigma-Aldrich, Dorset, UK) in order to facilitate cell lysis and the removal of cellular components, respectively. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Vac-SDS
All samples processed through each of the decellularisation methodologies were either preserved in PBS for DNA and GAG (n=3) analysis or fixed in 10% neutral buffered formalin-saline (NBF) for histological analysis (n=3).
Assessment of cellular content removal
Histological analysis
Histological examination was used to assess cellular clearance and gross tissue morphology. Briefly, samples from each of the methodologies, along with a control sample, were fixed in 10% NBF for 24 hours at room temperature. The samples were processed for paraffin wax embedding using routine histological techniques. Subsequently, 5 µM thickness paraffin sections were cut using a rotary microtome (ThermoFisher, Bedford, UK). The sections were mounted onto poly-lysine coated histology slides (ThermoFisher, Bedford, UK) and stained with haematoxylin and eosin according to routine procedures. Additional sections were stained with 4′, 6-diamidino-2-fenylindool (DAPI) and visualised using inverted Axio fluorescence imager (Zeiss, UK). Nuclei were quantified using ImageJ (NIH). Based on histological examination the Vac-SDS was eliminated at this stage from further analysis.
DNA quantification.
To assess the quantity of DNA present, cartilage samples were cryomilled using a This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Protein extraction and Western blotting for alpha-Gal content.
Western blot analysis was utilised to determine the presence of the Alpha-Gal epitope.
Briefly, Control cartilage, muscle and Vac-OS decellularised cartilage (dcECM) were cryomilled using a SPEXSamplePrep 6775 freezer mill (SPEX, London, UK) to form a paste.
To further solubilise, 200 mg of the sample paste was combined with 1 mL of RIPA buffer (Sigma-Aldrich, Dorset, UK) and frozen at -80 o C until analysed. The total protein content of the lysate was quantified using a BCA protein assay kit (ThermoFisher, Bedford, UK) in accordance with the manufacturer's instructions. 10 µg of the protein was combined with 2 x Laemmli sample buffer in a 1:1 ratio containing β-mercaptoethanol (Sigma-Aldrich, Dorset, UK) and size fractionated using SDS-PAGE, run on Mini-PROTEAN® TGX™ Precast Gels (Biorad, Herts, UK) followed by electrotransfer using the Trans-Blot® Turbo™ Mini PVDF Transfer Packs (Biorad, Herts, UK). The transferred proteins were stained using 1%
Ponceau S (Sigma-Aldrich, Dorset, UK) for 1 hour. The blots were then blocked using 3% filtered bovine serum albumin (Sigma-Aldrich, Poole, UK), and incubated overnight at 4°C
with an antibody against Alpha-Gal (EnzoLifeSciences, Exeter, UK) at 1:500 dilution. A secondary anti-mouse HRP conjugated antibody (VectorLabs, Cambs, UK) was then added to the blot at the concentration of 1:1000 and incubated for 1 hour at room temperature.
Detected proteins were visualised using Clarity™ Western ECL Blotting Substrate (Biorad, Herts, UK) and images were obtained using ChemiDocXRS+ (Biorad, Herts, UK).
Analysis of matrix components
2.4.1. Sulphate glycosaminoglycan (sGAG) Quantification.
The sGAG content in both control cartilage samples and decellularised samples were measured using the Blyscan s-GAG assay kit (Biocolor, Ireland). Briefly, each sample was cryomilled using a SPEXSamplePrep 6775 freezer mill (SPEX, London, UK) and 50mg of the sample was placed in 1.0 mL papain digestion buffer containing 400 mg sodium acetate, 200 mg EDTA disodium salt, 40 mg cysteine HCL and 0.1mg papain for 12 hours at 65°C
with occasional mixing. The digests were centrifuged at 13,000 rpm for 10 minutes. 50 µL of each digest supernatant was mixed with 1.0 mL Blyscan dye reagent. The samples were mixed for 30 minutes using an orbital shaker (IKA, Staufen, Germany), followed by nm. Absolute sGAG content in µg/mL was determined and samples normalised to the wet mass of each sample.
Differential scanning calorimetry (DSC).
DSC was used to measure collagen denaturation temperatures as an indicator of the structural integrity of the matrix. Control native cartilage samples were compared to dcECM samples. Briefly, 10 mg of each sample was placed into 40 µL aluminium crucibles.
The calorimetric experiments were performed using Mettler Toledo DSC-1 calorimeter (Mettler Toledo, Greenfield, UK). All experiments were performed between 25°C and 95°C at a heating rate of 3°C/min. The readings were normalised to an empty reference crucible.
Multiphoton imaging
Second harmonic generation and fluorescence-lifetime imaging microscopy (FLIM) were used to measure changes in the collagen biochemical environment as a measure of matrix integrity. Native costal cartilage and dcECM were placed in PBS in preparation for imaging.
Laser scanning microscopy with multiphoton excitation was carried out using a Zeiss LSM 510 microscope (Zeiss, Oberkochen, Germany) with a 10x 0. 
In vitro biocompatibility of dcECM
Human articular chondrocyte isolation.
Human cartilage was harvested from the articular surfaces of the knee and hip from patients undergoing joint replacement surgeries. Articular chondrocytes were extracted from cartilage using a methodology that was adapted from previous studies [34] [35] [36] [37] .
Briefly, two grams of cartilage were finely minced and placed into a collagenase type IV 
Chondrocyte seeding and micromass culture.
Human primary articular chondrocytes were thawed, sub-cultured and upon confluence at passage 3, were seeded in micromass cultures directly onto the plastic surface or onto dcECM at a density of 5x10 5 per 100 µL of growth media into the centre of a well.
Micromass culture is extensively used in chondrogenic differentiation protocols as it effectively mimics cell aggregation and allows an intra-aggregate environment to be acquired that is permissive for differentiation [38] . These events mimic those that occur in vivo during limb development. Briefly, dcECM was cut into 6 mm diameter and 1 mm thick This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
sections using a biopsy punch (ThermoFisher, Bedford, UK). 5x10 5 chondrocytes in 10 µL of growth media were seeded onto the surface of the dcECM, whereby the low seeding volume aided localisation of the cells on the surface of the dcECM until attachment. Cells were seeded in micromasses and onto the dcECM surface at the same density. The cells were left for 3 hours to attach, following which 2 mL of growth media supplemented with 5% FBS was added, micromasses were cultured in these conditions for a period of 7 days (n=3 per group). The media in each well was replaced daily with fresh growth media.
Human periosteal stem cells (hPDSCs).
hPDSCs were isolated as previously described [37] (obtained from Prof Frank Luyten, KU Leuven, Belgium). Subsequently, hPDSCs from a pool of six different donors were expanded to passage 5. All experiments described herein were performed in pooled hPDSCs at passage 6.
hPDSC seeding and micromass culture.
Micromass cultures (MM) were seeded as previously described. Briefly, hPDSCs (passage 6) were seeded at a cell density of 1x10 6 per 100 µL of growth media into 96-well plates.
Cells were seeded at this density onto the dcECM as previously described and allowed to attach for 3 hours before being treated with various chondrogenic media. The cells seeded in micromasses and on the dcECM were segregated into 3 media condition groups This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Total RNA extraction and quantitative reverse transcription-Polymerase Chain
Reaction (qRT-PCR) analysis.
Total RNA was extracted using the Trizol method. Briefly, seeded dcECM constructs were washed with PBS, placed in 350 μL of Trizol (Invitrogen, Paisley, UK) and homogenised.
Total RNA was isolated from each of the micromasses and dcECM using the Direct-zol RNA s at 60°C, and 20s at 72°C, on a Bio-Rad CFX1000 Real-Time System (Biorad, Herts, UK).
Target gene quantification was achieved using the 2 -ΔΔCT method described by Livak et al [39] relative to hPRT1 as the housekeeper gene. Primer sequences are listed in Supplementary Table 2 .
In vivo biocompatibility
6-week old BALB/C mice were purchased from Charles River, UK and were housed in polypropylene cages at 21°C (±2°C), subjected to 12-hour light and dark cycles, and were 
Statistical analysis
Data are expressed as the mean ± standard deviation (SD). Statistical significance was determined using one-way analysis of variance (ANOVA) with Bonferroni's posthoc This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
corrections applied and Student's t-test with Welch's posthoc corrections applied to compare between independent groups. Statistical significance is indicated on all graphs as follows: *p<0.05, **p<0.01, ***p<0.001 (n=3). All statistical analysis was performed using GraphPad Prism version 6.0f for windows (GraphPad Prism Software, La Jolla California USA, www.graphpad.com).
Results
An optimised Vac-OS decellularised methodology results in the effective removal of cellular components.
Light microscopy of H&E stained sections revealed that all methodologies resulted in some level of cellular clearance, with the Vac-OS and Vac-STx methodologies resulting in the greatest clearance (Fig 1A) . This was further validated through nuclear staining with DAPI and subsequent quantification (Fig 1B) . The Vac-SDS based methodology resulted in an 89.5% (p<0.001) reduction in DAPI positive nuclei. The Vac-STx and Vac-OS methodologies were the most effective at clearing cellular and nuclear content from the cartilage samples as evidenced by a 100% (p<0.001) reduction in visible DAPI positive nuclei. These two methodologies were therefore chosen for further characterisation and assessment.
Vac-OS decellularisation results in superior sGAG retention and the efficient removal of the Alpha-Gal epitope.
To validate the effective removal of cellular and nuclear content from the decellularised cartilage samples the DNA content of the tissue was analysed. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Despite the similarity in DNA content, distinct differences in sGAG retention (Fig 2; C&D) between the two methodologies and tissue volumes were observed. This difference in sGAG retention was not observed between the two methodologies in the smaller tissue volume. The Vac-OS decellularisation with larger tissue volumes was thus selected as the optimal methodology for costal cartilage and subjected to further analysis.
The presence of alpha-Gal epitope, which is an abundant immunogenic component found on the cell surface of all non-primate species, was investigated [40] . Immunoblotting revealed a 56 kDa band, indicating alpha-Gal was present (Fig 2F; protein loading is shown in Fig 2E) in control muscle (lanes 1&2) and cartilage tissues (lanes 3&4), but was absent in the Vac-OS decellularised sample groups (lanes 5, 6, & 7).
Matrix analysis indicates minimal disruption to the Vac-OS decellularised matrix.
The matrix integrity of the Vac-OS decellularised samples was further assessed using thermal analysis to determine collagen denaturation temperatures, thus indicating collagen structural integrity. These analyses were compared to the collagen denaturation temperatures obtained from native costal cartilage. This analysis indicated that there were no significant changes in the denaturation temperatures between the dcECM compared to native costal cartilage (Fig 3; A&B) . This was further reflected in the matrix analysis carried out using multiphoton imaging techniques (Fig 3C-F) . The highly noncentrosymmetric structure of fibrillar collagen gives rise to intense second harmonic generation when exposed to a high-intensity coherent light source [41] . This allows collagen structures to be imaged using laser scanning microscopy by observing light emitted from a sample at half the wavelength of the incident illumination. Collagen also possesses intrinsic fluorescence properties due to the presence of a range of spectrally-overlapping endogenous This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
fluorophores [42] . Changes in the nanoscale local environment of these fluorophores are reflected by alterations in their fluorescence lifetime [43] , the average time taken for emission to occur following excitation. Combining second harmonic and fluorescence lifetime imaging would allow the assessment of morphological changes within the extracellular matrix. Remarkably, there was no significant difference between control and dcECM fluorescence lifetimes, suggesting minimal changes in the biochemical environment of the extracellular matrix following the Vac-OS decellularisation process compared to native cartilage (Fig 3F) . In contrast, dcECM treated with collagenase demonstrated both reduced collagen denaturation temperatures and altered fluorescence lifetimes ( Supplementary Fig 1) .
dcECM promotes chondrogenic differentiation of skeletal cells.
To assess the capacity for cell attachment and promotion of a chondrogenic phenotype, de-differentiated human chondrocytes were seeded onto the dcECM (Fig 4) . Cell attachment onto the dcECM was illustrated by nuclear and cytoskeletal staining (Fig 4A) , revealing that the attached cells migrated into the vacant chondrocyte lacunae.
Furthermore, the establishment of a chondrogenic phenotype of seeded cells was confirmed by a significant 4-fold (p<0.01) increase in COL2A1 mRNA expression associated with cartilage matrix maintenance (Fig 4B) . There was no significant difference in chondrogenic commitment marker SOX9 mRNA expression. To further examine the chondrogenic potential of the scaffolds, hPDSCs were seeded onto the dcECM and in micromasses, and examined for cell attachment (Fig 4C) . Cells within micromasses under control conditions appeared more elongated with fibroblast-like morphology, whilst those under C(+) conditions (containing TGF-β) displayed a more distinct rounded morphology indicative of chondrocytic phenotype after 7 days (Fig 4C) . To understand these observations and assess the interaction of the cells with the dcECM, hPDSCs seeded onto the dcECM and in micromasses were either stimulated with C(+) or cultured under control conditions. Chondrogenic gene marker expression after 7 days was assessed (Fig 4D) .
There was no significant change in any of the markers between cells seeded onto the dcECM and micromasses under control conditions. In contrast, under chondrogenic (C+)
conditions there was a significant upregulation of the SOX-trimer; SOX9; SOX5 and SOX6 This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Discussion
There is currently an unmet clinical need for treatment approaches aimed at enhancing the fracture repair process for the treatment of fracture non-union. Herein, we describe the production of innovative hyaline cartilage scaffolds that retain the native ECM architecture and biological cues required to enhance skeletal cell differentiation.
Effective decellularisation is reliant on the efficient elimination of immunogenic cellular components without interfering with the intended biological function of the resultant ECM scaffold. This is particularly challenging with dense avascular tissues such as cartilage [44, 45] . Recent studies applying vacuum-assisted decellularisation demonstrate increased decellularisation efficiency, especially with respect to complex organs that include dense tissues i.e. trachea and larynx [33, 46] . The enhanced cellular clearance reduces the need for harsh physical or enzymatic treatments that may contribute to the loss of bioactive molecules from the ECM [33, 46] . Similarly, osmotic shock has also been applied towards the efficient decellularisation of dense tissues with minimal ECM disruption [32, 47] and was therefore combined with vacuum assistance to formulate the optimised Vac-OS methodology (Supplementary Table 1 ) used in this study. This methodology (Vac-OS) was also compared to previously used vacuum-assisted decellularisation (Vac-STx) that incorporated the detergents triton-x and sodium deoxycholate (SDC) [33] . Interestingly, despite the Vac-OS methodology lacking any ionic surfactants, the resultant scaffolds (dcECM) exhibited DNA content falling below levels that are known to be immunogenic in vivo [22] . In addition, enhanced sGAG retention was also observed with the Vac-OS methodology compared to both the Vac-STx and other published methodologies aimed at decellularising cartilaginous tissues [25, 48] .
sGAGs are present in various tissue types but are especially abundant in cartilaginous ECM, serving as both structural and functional components [26, 49] . Besides their role in ECM homoeostasis [50] , sGAGs have also been associated with their ability to drive chondrogenesis [51] [52] [53] and in the regulation of endochondral ossification [54] . Therefore, the maintenance of sGAG content is essential when developing a scaffold with a capacity for endochondral ossification from cartilage tissue. Indeed, the Vac-OS methodology This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
allowed for the retention of up to 85% of the native sGAG content, which was observed specifically when tissue volume was upscaled by a factor of ten. The synergy between osmotic shock and vacuum assisted decellularisation was further highlighted by the enhanced retention of GAGs compared to the Vac-STx methodology. These findings suggest that the disruptive and proteolytic nature of ionic surfactants such as SDC [55] may be key facilitators of sGAG loss. Indeed, several other studies that employ the use of ionic surfactants and enzymes report similar findings [25, 56, 57] .
A key promoter of xenogeneic transplant rejection is the alpha-gal epitope, which is a cellular component found on all non-primate species and is known to elicit an acute inflammatory response in humans. [40] . Therefore, the reduction or elimination of this key antigen is essential for clinical translation [58] [59] [60] . Moreover, the presence of residual alpha-gal in commercially available xenografts has been shown to have negative clinical outcomes [61] [62] [63] . Encouragingly, the high level of alpha-gal present within native costal cartilage tissue was successfully reduced below detectable levels by the Vac-OS methodology.
The ECM structure and 3D spatial arrangement of macromolecules both play a vital role in cellular adhesion, stem cell fate determination and in vivo tissue remodelling [64] [65] [66] .
Maintenance of ECM structure should, therefore, be thoroughly considered during the development decellularisation methodologies. Most studies utilise standard histological techniques for the assessment of decellularised cartilaginous matrices, which only allow for the gross examination of matrix architecture [67, 68] . Therefore, DSC was used to gain an enhanced understanding of the dcECM collagen integrity. Interestingly, it has previously been reported that alterations in articular cartilage matrix integrity between healthy and osteoarthritic cartilage are reflected by variations in the collagen denaturation temperatures [69] . Therefore, the unaffected collagen denaturation temperatures between the native costal cartilage and the dcECM are reflective of the preservation of collagen ultrastructure post Vac-OS. Unfortunately, DSC is destructive and only provides a global view of matrix integrity, hence, FLIM was utilised as an alternative approach to monitor subtle changes in the ECM. It is widely accepted that site-specific changes in collagen cross-linking can be identified through imaging techniques that quantify the This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
lifetimes of collagen auto-fluorescence [70] . In agreement with the DSC data, the FLIM analysis did not uncover any significant changes in collagen fluorescence lifetimes between the dcECM scaffolds and native costal cartilage. To our knowledge, this is the first report of FLIM being used to assess matrix integrity of decellularised ECM that could be widely applied in the nondestructive monitoring of tissue during the optimisation of decellularisation approaches.
The successful clinical application of a tissue-engineered implant depends on its ability to attract and direct tissue-specific remodelling via its interaction with surrounding stem cell populations. Chondrocytes are a cell type native to hyaline cartilage and are involved in cartilage homoeostasis [71] , however, they are known to rapidly lose their chondrocytic phenotype following culture in monolayer [72, 73] . Interestingly, dcECM promoted the reestablishment of a chondrogenic phenotype from culture expanded (dedifferentiated)
chondrocytes, indicated by a significant upregulation of COL2A1expression. This is potentially the result of the retention of sufficient sGAG content [49, 74, 75] , an undisrupted ECM ultrastructure [76] and, although not investigated in this study, the presence of remnant growth factors such as TGF- [77] , BMP2 [78] , FGF-2 and FGF-18 [79] .
To further elucidate the chondrogenic capacity of dcECM, human periosteal stem cells (hPDSCs), which are essential for fracture repair [80] [81] [82] [83] , were investigated. When combined with the dcECM, hPDSCs significantly upregulated expression of the chondrocyte genes SOX9, SOX5, SOX6, COL2A1 and ACAN. Interestingly, there was also a upregulation of COL10A1, RUNX2 and VEGFA, which are representative of chondrocyte hypertrophy [10, 84, 85] . Moreover, these events were detected following a period of just 7 days. Interestingly, the upregulation of chondrogenic and hypertrophic markers were only observed in seeded dcECM constructs, cultured in conditions containing TGF-β. This may be due to the ability of the retained GAGs to sequester exogenously added TGF-β, thus enhancing its chondrogenic potential [49, 74, 75] .
For the successful translation of tissue engineered constructs, they must elicit a favourable immune response upon implantation, whilst avoiding a pro-inflammatory response that could hinder the natural tissue repair cascade and/or result in tissue rejection. The immunogenicity of the dcECM was therefore assessed in vivo through subcutaneous This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
implantation into immunocompetent mice. The dcECM demonstrated a predominantly M2 biased response at 2 and 8 weeks, which is indicative of favourable long-term outcomes and tissue-specific remodelling [86] . This was in contrast to the native costal cartilage comparator that demonstrated a predominantly M1 mediated response, which is linked to the initiation of inflammation. This further supports the in vitro analysis that demonstrates the effective removal of immunogenic factors.
The validity of using decellularised cartilage tissue as an endochondral substrate has been previously demonstrated by Gawlitta and colleagues [25] and Cunniffe and colleagues [27] .
The choice of articular cartilage-derived scaffolds used in the study by Gawlitta is, however, questionable as articular cartilage is highly stable during adult life, except in disease conditions [87] . Indeed, factors such as chondromodulin 1 (ChM-I) have been implicated in the stability of articular cartilage by inhibiting angiogenesis [88] , a process essential for endochondral fracture healing [2] . Furthermore, Cunniffe and colleagues demonstrated that only scaffolds derived from in vitro hypertrophic chondrocyte ECM promoted vascularisation, induced mineralization and promoted bone formation [27] . Their use of cell-derived cartilage scaffolds, however, will pose major challenges when considering the fabrication of constructs of a clinically viable size [27, 89, 90] . Work carried out by Scotti and colleagues attempted to overcome this limitation by upscaling the size of previously developed cell constructs [89] through the addition of a collagen type I scaffold [91] . Although the approach yielded constructs capable of undergoing endochondral ossification, the efficacy of the process still remains highly reliant on an abundant stem cell population and extended culture periods.
Conclusion
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